BSE filing, NSE: RCIIND. Summary written from the filing by ALFA Finder's alert engine.
JTL Defence Ltd: key numbers
- Share price
- ₹548.65
- Market cap
- ₹577.5 Cr
- Revenue (annual)
- ₹19.29 Cr
- Net profit (annual)
- ₹0.27 Cr
- P/E (TTM)
- -159.0×Sector 16.5×
- Promoter holding
- 95.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JTL Defence Ltd
All →JTL Defence Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs197 Mn, EBITDA Rs23 Mn (11.4% margin), reported PAT loss Rs26 Mn; adj. PAT Rs1 Mn. H1 revenue Rs410 Mn, EBITDA margin 11.5%.
JTL Defence Q2 FY27 Results: Net Loss of ₹2.6 Cr
JTL Defence Ltd reported revenue from operations of ₹19.7 Cr (+447.2% YoY) and a net loss of ₹2.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹2.6 Cr
JTL Defence Insolvency Petition
JTL Defence Ltd implemented its IBC resolution plan, allotting 1 crore equity shares worth ₹10 crore to JTL Industries Ltd, restructuring the company's capital.
- Value
- ₹10.00 Cr
JTL Defence Management Change
JTL Defence Limited appointed Saurabh Jain as CFO and Devangna Jain as Company Secretary, following the resignations of Naveen Kumar Laroiya and Ankit Singla.
JTL Defence Fund Raise of ₹24.6 Cr
JTL Defence Ltd board approved a rights issue of equity shares worth up to Rs. 24.6 Crore. Additionally, it announced changes in key management personnel.
- Value
- ₹24.60 Cr
JTL Defence Other Announcement
JTL Defence has disbursed net proceeds from the sale of fractional shares to eligible shareholders, following the approved resolution plan and capital reduction process.
Other results update announcements
All →Wonderla Holidays Results Update
Wonderla reports best-ever Q2 with 42% income growth to ₹126 Cr and 90% EBITDA growth. H1 income up 41% to ₹378 Cr driven by new Chennai park.
UPL Results Update
UPL's Q2 FY27 revenue was ₹11,860 Cr with EBITDA of ₹2,312 Cr. H1 operational PATMI rose 33% YoY on sustained margin expansion.
Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
Mold-Tek Packaging Results Update
Mold-Tek reported Q2 FY27 net profit up 36% to Rs 21.06 Cr and H1 profit up 23% to Rs 46.67 Cr. Revenue and sales volumes also rose across both periods.
Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.
Eureka Forbes Results Update
Eureka Forbes reported Q2 FY27 revenue of ₹889.6 Cr and PAT of ₹73.3 Cr, both up ~19% YoY. EBITDA margin hit a lifetime high of 13.6%.